What Researchers Did
Researchers investigated whether adding hyperbaric oxygen therapy (HBOT) to standard care could improve outcomes for 63 newborns with severe jaundice and other health issues.
What They Found
In the group receiving HBOT, indirect bilirubin levels decreased 40% more rapidly compared to controls. This group also showed reliably improved liver conjugation function by days 3-4, normalized enzymatic liver function by day 5, and resolution of mixed acidosis in over 90% of patients within the first day. Additionally, adequate glycemia and serum albumin concentrations were achieved sooner, and the need for extracorporeal detoxification decreased.
Canadian Relevance
The study was not conducted by Canadian authors or in Canada. Neonatal jaundice is not currently a Health Canada-recognised indication for hyperbaric oxygen therapy. Therefore, no direct Canadian connection is identified.
Study Limitations
The study was conducted in 1997 with a relatively small sample size, and the specific hyperbaric oxygen therapy protocols, such as pressure and duration, were not detailed in the abstract.